Local News: Brunei 

 | 

Sign Up

 | 

Sign In

Advertisment

Ranbaxy Laboratories

Ranbaxy Laboratories Wire

Comprehensive News Feed for Ranbaxy Laboratories.

Results 1 - 20 of 175 in Ranbaxy Laboratories

  1. AstraZeneca makes peace with Teva to protect Nexium salesRead the original story

    7 hrs ago | The Independent

    ... with a generics company over Nexium. Two years ago, it did a similar deal with the Indian company Ranbaxy Laboratories. Both Teva and Ranbaxy will now be able to start marketing a copy of Nexium in May 2014, the date on which AstraZeneca's first ...

    Comment?

    Related Topix: Biotech, Medicine, AstraZeneca Group, Healthcare Industry

  2. Ranbaxy Laboratories in Talks to Acquire Bangalore Vaccine Company for Rs 50-cr

    Yesterday | BioSpace

    Indiatimes.com -- Ranbaxy Laboratories has started discussions to buy a privately-held Bangalore-based vaccine company, two persons familiar with the development said.

    Comment?

    Related Topix: Ranbaxy Laboratories, Biotech, Healthcare Industry

  3. Ranbaxy launches anti-fungal chemicalRead the original story

    Tuesday | The Hindu

    MUMBAI: Drug major Ranbaxy Laboratories has launched a new chemical, Lulifin , used in the treatment of fungal infection.

    Comment?

    Related Topix: Ranbaxy Laboratories, Biotech, Healthcare Industry

  4. Implanting new ideas into next generation depot syringes

    Tuesday Jan 5 | IN-Pharmatechnologist.com

    Ranbaxy Laboratories has sold its Chinese JV, Ranbaxy Guangzhou China Limited , as part of a new approach to the country's rapidly expanding drug market.

    Comment?

    Related Topix: Biotech, Ranbaxy Laboratories, Healthcare Industry, Guangzhou, China, Guangdong, China, World News, China, H1N1 Influenza / Swine Flu, Health, Outsourcing, US News

  5. China Biotech Week in Review: Year-End IPOsRead the original story

    Monday Jan 4 | Seeking Alpha

    ... Medical (NYSE: CCM ) and China Cord Blood (NYSE: CO ) did not fare particularly well in their debuts. Ranbaxy Laboratories ( RBXLF.PK ) has sold its share in a China manufacturing JV, Ranbaxy Guangzhou China (RGCL), to HNG Chembio Pharmacy Co Ltd. ...

    Comment?

    Related Topix: World News, China, Asia, Guangzhou, China, Guangdong, China

  6. Ranbaxy launches anti-fungal chemical in India

    Monday Jan 4 | Mydigitalfc.com

    Drug major Ranbaxy Laboratories today said it has launched a new chemical, Lulifin , used in the treatment of fungal infection.

    Comment?

    Related Topix: Biotech, Ranbaxy Laboratories, Healthcare Industry, Medicine, Dermatology, Marketing

  7. Japan warms relations with India but future accord remains hazyRead the original story

    Wednesday Dec 30 | Xinhuanet

    ... the back of a series of successful tie ups. The Tata-DoCoMo tie-up and the Daiichi Sankyo venture with Ranbaxy Laboratories, perceptibly contributed to annual trade figures between the two countries and the success of the collaborations has seen the ...

    Comment?

    Related Topix: World News, India, Asia, Manmohan Singh, Mukesh Ambani, Maharashtra, India, Mumbai, India

  8. Ranbaxy sells stake in Chinese joint ventureRead the original story

    Tuesday Dec 29 | The Telegraph

    New Delhi, Dec. 29: Ranbaxy Laboratories has sold its entire stake in Chinese joint venture Ranbaxy Ghuangzhou China Limited to HNG Chembio Pharmacy Company for an undisclosed amount.

    Comment?

    Related Topix: Ranbaxy Laboratories, Biotech, Healthcare Industry

  9. Ranbaxy exits Chinese JVRead the original story

    Tuesday Dec 29 | Express India

    ... Wednesday, Dec 30, 2009 at 0000 hrs IST Updated: Wednesday, Dec 30, 2009 at 0000 hrs IST Mumbai: Ranbaxy Laboratories has sold its entire stake in Chinese joint venture, Ranbaxy Ghuangzhou China (RGCL), to HNG Chembio Pharmacy Co Ltd for an ...

    Comment?

    Related Topix: Ranbaxy Laboratories, Biotech, Healthcare Industry, Marketing

  10. Ranbaxy exits Chinese joint ventureRead the original story

    Tuesday Dec 29 | The Hindu

    NEW DELHI: Ranbaxy Laboratories on Tuesday announced its exit from the Chinese joint venture stating it had sold its entire stake in the venture, Ranbaxy Ghuangzhou China, to HNG Chembio Pharmacy Co Ltd for an undisclosed amount.

    Comment?

    Related Topix: Ranbaxy Laboratories, Biotech, Healthcare Industry

  11. Ranbaxy exits from China venture

    Tuesday Dec 29 | Hindustan Times

    Ranbaxy Laboratories has sold its entire stake in Chinese joint venture - Ranbaxy Guangzhou China Ltd - to HNG Chembio Pharmacy Co Ltd for an undisclosed amount.

    Comment?

    Related Topix: Biotech, Ranbaxy Laboratories, Healthcare Industry, Guangzhou, China, Guangdong, China, World News, China

  12. Ranbaxy again feels FDA heat - this time over US plantRead the original story

    Saturday Dec 26 | Domain-B

    Delhi-based drug manufacturer Ranbaxy Laboratories has received a warning from the Food and Drug Administration over violation of good manufacturing practices norms at one of its manufacturing facilities in the US, the company said in a statement on Thursday.

    Comment?

    Related Topix: Food and Drug Administration, US Energy Systems, Energy, Biotech

  13. FDA hauls up Ranbaxy US unit for deviationsRead the original story

    Thursday Dec 24 | Express India

    ... added. Ohm Laboratories Inc, based in North Brunswick, New Jersey, USA, is a wholly-owned subsidiary of Ranbaxy Laboratories Ltd. Ohm is engaged in sale and distribution of generic and branded private label, OTC products in the US healthcare system. ...

    Comment?

    Related Topix: US Energy Systems, Energy, Food and Drug Administration, World News, India, New Delhi, India, Haryana, India, Gloversville, NY

  14. How top Indian drug firms are pushing up salesRead the original story

    Wednesday Dec 23 | Welcome to rediff.com

    ... plans are to tap the Rs 80-crore scar and marks removal cream market in India. A few months ago, Ranbaxy Laboratories had in-licensed an anti-ageing drug Neuronox from Medy-Tox of South Korea. The market size for this drug in India is estimated at ...

    Comment?

    Related Topix: Biotech, Wockhardt, Medicine, Dermatology, Marketing

  15. Column: Daiichis safariRead the original story

    Tuesday Dec 22 | Express India

    MG Arun Posted: Wednesday, Dec 23, 2009 at 2054 hrs IST Updated: Wednesday, Dec 23, 2009 at 2054 hrs IST : The synergies between Ranbaxy Laboratories and its owner Daiichi Sankyo have been unravelling over the last few months, much to the relief of investors in the Indian company.

    Comment?

    Related Topix: Ranbaxy Laboratories, Healthcare Industry, Marketing

  16. Big Pharma's Love-Hate With IndiaRead the original story

    Tuesday Dec 22 | Minyanville

    ... are mostly independent and highly entrepreneurial, that compete in this area. The two exceptions are Ranbaxy Laboratories, which was bought by Japan's Daiichi Sankyo in 2007, and Matrix Pharmaceuticals, a subsidiary of generic drugmaker Mylan ( MYL ...

    Comment?

    Related Topix: Biotech, Advance, IN, Outsourcing, Dr Reddys Laboratories

  17. Ranbaxy to make presence in African region

    Monday Dec 21 | The Hindu

    CHENNAI: Daiichi Sankyo Company and Ranbaxy Laboratories have announced that Ranbaxy will launch Olmesartan Medoxomil, an anti-hypertensive, originally discovered by Daiichi Sankyo in six African countries.

    Comment?

    Related Topix: Ranbaxy Laboratories, Biotech, Healthcare Industry

  18. Ranbaxy to launch anti-hypertensive drug in six African countriesRead the original story

    Monday Dec 21 | Domain-B

    Daiichi Sankyo Company Limited and Ranbaxy Laboratories Limited, today announced that Ranbaxy would launch Olmesartan Medoxomil, an anti-hypertensive drug originally synthesised by Daiichi Sankyo, in six African countries.

    Comment?

    Related Topix: Biotech

  19. Ranbaxy to launch 'Olmesartan Medoxomil' in 6 African countriesRead the original story

    Monday Dec 21 | Newkerala.com

    New Delhi, Dec 21 : Pharma major Ranbaxy Laboratories Ltd will launch 'Olmesartan Medoxomil', an antihypertensive, in six African countries such as Kenya, Mozambique, Nigeria, Tanzania, Uganda and Zambia.

    Comment?

    Related Topix: India, New Delhi, India, Haryana, India, World News, Biotech

  20. As molecule deals fall, pharma firms see cure in late licensingRead the original story

    Saturday Dec 19 | Business Standard

    ... in their research and development spend in the days of economic slowdown," said an industry expert. Ranbaxy Laboratories, which became a subsidiary of Japanese drug major Daiichi Sankyo last year, had outlicensed a prostate enlargement drug ...

    Comment?